These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23480488)

  • 1. Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders.
    Molero-Luis M; Serrano M; Ormazábal A; Pérez-Dueñas B; García-Cazorla A; Pons R; Artuch R;
    Dev Med Child Neurol; 2013 Jun; 55(6):559-66. PubMed ID: 23480488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
    Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
    Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary abnormalities of neurotransmitters in infants with neurological disorders.
    García-Cazorla A; Serrano M; Pérez-Dueñas B; González V; Ormazábal A; Pineda M; Fernández-Alvarez E; Campistol JM; Artuch RM
    Dev Med Child Neurol; 2007 Oct; 49(10):740-4. PubMed ID: 17880642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
    Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
    Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism.
    Van Der Heyden JC; Rotteveel JJ; Wevers RA
    Eur J Paediatr Neurol; 2003; 7(1):31-7. PubMed ID: 12615172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
    Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
    Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
    Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolites of neurotransmitters in the cerebrospinal fluid in children].
    Zeman J; Böswart J
    Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
    Rapoport SI; Schapiro MB; May C
    Arch Neurol; 2004 Nov; 61(11):1721-4. PubMed ID: 15534183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience.
    Batllori M; Molero-Luis M; Ormazabal A; Montero R; Sierra C; Ribes A; Montoya J; Ruiz-Pesini E; O'Callaghan M; Pias L; Nascimento A; Palau F; Armstrong J; Yubero D; Ortigoza-Escobar JD; García-Cazorla A; Artuch R
    J Inherit Metab Dis; 2018 Nov; 41(6):1147-1158. PubMed ID: 29974349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial diseases mimicking neurotransmitter defects.
    Garcia-Cazorla A; Duarte S; Serrano M; Nascimento A; Ormazabal A; Carrilho I; Briones P; Montoya J; Garesse R; Sala-Castellvi P; Pineda M; Artuch R
    Mitochondrion; 2008 Jun; 8(3):273-8. PubMed ID: 18558519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid homovanillic acid in cerebral infarction.
    Hachinski V; Shibuya M; Norris JW; Hornykiewicz O
    J Neural Transm Suppl; 1978; (14):45-50. PubMed ID: 290739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homovanillic acid in human cerebrospinal fluid.--Its concentration gradient and reduced levels in patients with epilepsy.
    Kobayashi K; Koide Y; Doi T; Kohsaka M; Hosokawa K; Oku Y
    Acta Med Okayama; 1978 Aug; 32(4):293-300. PubMed ID: 153090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Vilanakis E; Papakonstantinou E; Paramera E; Argyri I; Drakou E; Kokkinou E; Zouvelou V; Outsika C; Pons R
    Neuropediatrics; 2023 Apr; 54(2):126-133. PubMed ID: 36442788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
    Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
    Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters.
    Sher L; Mann JJ; Traskman-Bendz L; Winchel R; Huang YY; Fertuck E; Stanley BH
    J Affect Disord; 2006 Jan; 90(1):83-9. PubMed ID: 16310257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcome of 6-pyruvoyl-tetrahydropterin synthase-deficient patients.
    Manti F; Nardecchia F; Banderali G; Burlina A; Carducci C; Carducci C; Donati MA; Gueraldi D; Paci S; Pochiero F; Porta F; Ortolano R; Rovelli V; Schiaffino MC; Spada M; Blau N; Leuzzi V
    Mol Genet Metab; 2020; 131(1-2):155-162. PubMed ID: 32651154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.